Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology

Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology

Paul J McKiernan,2 Orla Cunninghamm,1,2 Catherine M Greenem,2 Sally-Ann Cryan1,31School of Pharmacy, Royal College of Surgeons in Ireland, 2Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland Education and Research Centre, Beaumont Hospital, 3Trinity Centre fo...

Full description

Bibliographic Details
Main Authors:	McKiernan PJ, Cunningham O, Greene CM, Cryan SA
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-10-01
Series:	International Journal of Nanomedicine
Online Access:	http://www.dovepress.com/targeting-mirna-based-medicines-to-cystic-fibrosis-airway-epithelial-c-a14667

Similar Items

MicroRNA Dysregulation in Cystic Fibrosis
by: Paul J. McKiernan, et al.
Published: (2015-01-01)

Investigation of miRNA Functionality in Cystic Fibrosis
by: Maryam Hassanzad, et al.
Published: (2019-09-01)

Inflammatory signalling pathways in cystic fibrosis airway epithelial cells
by: Lavelle, Michaela J.
Published: (2002)

MicroRNA Expression in Cystic Fibrosis Airway Epithelium
by: Catherine M. Greene
Published: (2013-02-01)

MiRNA Expression Profile in the Airways is Altered during Pulmonary Exacerbation in Children with Cystic Fibrosis—A Preliminary Report
by: Zuzanna Stachowiak, et al.
Published: (2020-06-01)

Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
by: Andrew Berical, et al.
Published: (2019-02-01)

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
by: Virginia De Rose, et al.
Published: (2018-01-01)

Electrochemical miRNA Biosensors: The Benefits of Nanotechnology
by: Mostafa Azimzadeh, et al.
Published: (2017-02-01)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
by: Virginia De Rose, et al.
Published: (2018-01-01)

Airways inflammation in cystic fibrosis
by: Downey, D. G.
Published: (2002)

Airway clearance in cystic fibrosis
by: McIlwaine, Patricia Margaret
Published: (2014)

Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis
by: Federica Zarrilli, et al.
Published: (2017-07-01)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin DA, et al.
Published: (2013-01-01)

Airway inflammation and remodelling in cystic fibrosis
by: Hilliard, Thomas Norman
Published: (2006)

Impaired Airway Epithelial Barrier Integrity in Response to Stenotrophomonas maltophilia Proteases, Novel Insights Using Cystic Fibrosis Bronchial Epithelial Cell Secretomics
by: Kevin Molloy, et al.
Published: (2020-02-01)

Gene therapy-emulating small molecule treatments in cystic fibrosis airway epithelial cells and patients
by: Q. Yang, et al.
Published: (2019-12-01)

Chemotaxis and Binding of Pseudomonas aeruginosa to Scratch-Wounded Human Cystic Fibrosis Airway Epithelial Cells.
by: Christian Schwarzer, et al.
Published: (2016-01-01)

Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells
by: Livia Delpiano, et al.
Published: (2018-12-01)

Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis
by: Laura M. Trandafir, et al.
Published: (2019-07-01)

The cystic fibrosis lower airways microbial metagenome
by: Patricia Moran Losada, et al.
Published: (2016-05-01)

New Developments in Cystic Fibrosis Airway Inflammation
by: Nades Palaniyar, et al.
Published: (2015-01-01)

Airway surface liquid antiviral activity in cystic fibrosis
by: Berkebile, Abigail Rae
Published: (2015)

L-ornithine derived polyamines in cystic fibrosis airways.
by: Hartmut Grasemann, et al.
Published: (2012-01-01)

Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways
by: Isaac Martin, et al.
Published: (2021-02-01)

The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis
by: Emer P. Reeves, et al.
Published: (2011-01-01)

Airway disease phenotypes in animal models of cystic fibrosis
by: Alexandra McCarron, et al.
Published: (2018-04-01)

Kluyvera ascorbata infection in Cystic Fibrosis airway disease
by: Antonietta Lambiase, et al.
Published: (2011-09-01)

Studies on Airway Surface Liquid in Connection with Cystic Fibrosis
by: Kozlova, Inna
Published: (2008)

The regulation of IL-8 function in the airways in cystic fibrosis
by: Perks, Beatrice
Published: (1999)

The metabolic footprint of the airway bacterial community in cystic fibrosis
by: Vaishnavi Narayanamurthy, et al.
Published: (2017-06-01)

Evaluation of apoptosis in cystic fibrosis epithelial cells
by: Chen, Q.
Published: (2012)

Airway Clearance Therapy in Cystic Fibrosis Patients Insights from a Clinician Providing Cystic Fibrosis Care
by: Chaudary N, et al.
Published: (2021-06-01)

Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
by: Nikhil T. Awatade, et al.
Published: (2018-12-01)

Studies of Tight Junctions and Airway Surface Liquid in Airway Epithelium with Relevance to Cystic Fibrosis
by: Nilsson, Harriet
Published: (2009)

Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
by: Carnovale Vincenzo, et al.
Published: (2006-01-01)

The microbial community of the cystic fibrosis airway is disrupted in early life.
by: Julie Renwick, et al.
Published: (2014-01-01)

Toothbrushes may convey bacteria to the cystic fibrosis lower airways
by: Rebeca Passarelli Mantovani, et al.
Published: (2019-01-01)

Salivary Cytokines and Airways Disease Severity in Patients with Cystic Fibrosis
by: Alice Castaldo, et al.
Published: (2020-04-01)

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
by: Edith T Zemanick, et al.
Published: (2013-01-01)

Culture enriched molecular profiling of the cystic fibrosis airway microbiome.
by: Christopher D Sibley, et al.
Published: (2011-01-01)